Authors
Latest:
Blase Polite on How Disparities Research Must Move Into an Era of ActionIn this interview we discuss health disparities in cancer care, how redesigning cancer clinical trials can address some of these disparities, and goals for the “next generation” of cancer health disparities research.
Latest:
Initiating Exercise Interventions to Promote Wellness in Cancer Patients and SurvivorsThis article includes a succinct review of current research into exercise in the cancer setting and a discussion of the American College of Sports Medicine exercise recommendations for cancer survivors. Common acute, long-term, and late effects of cancer and its treatment are also described in the context of ways in which these side effects impact the ability to exercise.
Latest:
Initiating Exercise Interventions to Promote Wellness in Cancer Patients and SurvivorsThis article includes a succinct review of current research into exercise in the cancer setting and a discussion of the American College of Sports Medicine exercise recommendations for cancer survivors. Common acute, long-term, and late effects of cancer and its treatment are also described in the context of ways in which these side effects impact the ability to exercise.
Latest:
Multidisciplinary Approaches to Chest Wall Recurrences of Breast CancerA chest wall recurrence of breast cancer following mastectomy is a complex clinical problem that can push centers to the limits of their resources.
Latest:
Multidisciplinary Approaches to Chest Wall Recurrences of Breast CancerA chest wall recurrence of breast cancer following mastectomy is a complex clinical problem that can push centers to the limits of their resources.
Latest:
Pneumonitis From Anti–PD-1/ PD-L1 TherapyWhile the incidence of irAEs is relatively low, the absolute number of patients receiving immune checkpoint inhibitors is steadily increasing. Thus, it is likely that, with time, larger numbers of patients will develop irAEs, including pneumonitis.
Latest:
Pneumonitis From Anti–PD-1/ PD-L1 TherapyWhile the incidence of irAEs is relatively low, the absolute number of patients receiving immune checkpoint inhibitors is steadily increasing. Thus, it is likely that, with time, larger numbers of patients will develop irAEs, including pneumonitis.
Latest:
Reducing Racial Disparities in Breast Cancer Care: The Role of 'Big Data'We will provide a brief orientation on the research that has defined our understanding of breast cancer disparities to date, as well as promising emerging data sources and methods that may take us further in the quest to close the racial survival gap and provide better cancer care to vulnerable populations.
Latest:
Reducing Racial Disparities in Breast Cancer Care: The Role of 'Big Data'We will provide a brief orientation on the research that has defined our understanding of breast cancer disparities to date, as well as promising emerging data sources and methods that may take us further in the quest to close the racial survival gap and provide better cancer care to vulnerable populations.
Latest:
Reducing Racial Disparities in Breast Cancer Care: The Role of 'Big Data'We will provide a brief orientation on the research that has defined our understanding of breast cancer disparities to date, as well as promising emerging data sources and methods that may take us further in the quest to close the racial survival gap and provide better cancer care to vulnerable populations.
Latest:
Determining Suitable Radioligand Therapy Use in Neuroendocrine TumorsOncologists discuss data from the NETTER-1 and NETTER-2 trials and the extent to which they support the applicability of 177Lu-dotatate in NETs.
Latest:
Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and ManagementIn this review, we focus on the treatment of well-differentiated early and metastatic PNETs, emphasizing current controversies, recent advances in therapy, and the multidisciplinary approach required for optimal treatment.
Latest:
Fumiko Chino, MD, on Next Steps in Evaluating Medicare’s Impact on Cancer Mortality RatesThe expert explained how states that expanded Medicaid coverage saw a steeper decline in cancer mortality rates, and next steps for further evaluation.
Latest:
Nonoperative Management of Rectal Cancer: A Modern PerspectiveIn this article, we provide a summary of nonoperative management of locally advanced rectal cancer in the modern era. Our focus is on technical details of tumor response and patient assessment after chemoradiotherapy, as well as a review of existing clinical data.
Latest:
Nonoperative Management of Rectal Cancer: A Modern PerspectiveIn this article, we provide a summary of nonoperative management of locally advanced rectal cancer in the modern era. Our focus is on technical details of tumor response and patient assessment after chemoradiotherapy, as well as a review of existing clinical data.
Latest:
Nonoperative Management of Rectal Cancer: A Modern PerspectiveIn this article, we provide a summary of nonoperative management of locally advanced rectal cancer in the modern era. Our focus is on technical details of tumor response and patient assessment after chemoradiotherapy, as well as a review of existing clinical data.
Latest:
Nonoperative Management of Rectal Cancer: A Modern PerspectiveIn this article, we provide a summary of nonoperative management of locally advanced rectal cancer in the modern era. Our focus is on technical details of tumor response and patient assessment after chemoradiotherapy, as well as a review of existing clinical data.
Latest:
POINT: Early Salvage vs Adjuvant Radiotherapy for High-Risk Prostate CancerSerial PSA testing with early salvage radiotherapy is a viable option in most high-risk men.
Latest:
COUNTERPOINT: Early Salvage vs Adjuvant Radiotherapy for High-Risk Prostate CancerThe data for adjuvant radiotherapy remain strong.
Latest:
Which Drug Is Contraindicated in RVD-Treated Multiple Myeloma Patients?Do you know when to switch treatment combinations or stop certain treatments altogether in the management of patients with multiple myeloma? Take part in a series of case scenarios and see if you can pick the correct course of action for each in our latest quiz.
Latest:
Pneumonitis From Anti–PD-1/ PD-L1 TherapyWhile the incidence of irAEs is relatively low, the absolute number of patients receiving immune checkpoint inhibitors is steadily increasing. Thus, it is likely that, with time, larger numbers of patients will develop irAEs, including pneumonitis.
Latest:
Pancreatic Neuroendocrine Tumors: State-of-the-Art Diagnosis and ManagementIn this review, we focus on the treatment of well-differentiated early and metastatic PNETs, emphasizing current controversies, recent advances in therapy, and the multidisciplinary approach required for optimal treatment.
Latest:
Early Palliative Care Improves QOL for Lung and GI Cancer PatientsThe early integration of oncology and palliative care enhanced coping strategies and improved QOL for patients newly diagnosed with incurable lung or GI cancer.
Latest:
Radiation Oncologist Speaks to AI Potential in the Cancer SpaceRichard Bakst, MD, speaks to the potential use of artificial intelligence in the radiation oncology space, and how he hopes to see it evolve.
Latest:
RT for Breast Cancer Patients Is 'Less Scary' Than AnticipatedThis video examines patient fears and misconceptions regarding radiation therapy for the treatment of breast cancer.
Latest:
Optimal Therapies for Metastatic Hormone-Sensitive Prostate CancerIn this interview we discuss the STOPCaP trial, a meta-analysis that looked at optimal systemic therapy options for men with metastatic hormone-sensitive prostate cancer.
Latest:
Genetic Variants Could Predict Cancer's Resistance to Radiation TherapyThis video highlights a large-scale profiling effort that seeks to identify and classify mutant alleles driving resistance to radiation therapy across different cancer types.
Latest:
Mucosal Melanoma: New Insights and Therapeutic Options for a Unique and Aggressive DiseaseHere, we review the features of mucosal melanoma that distinguish it from melanomas arising at other sites, and we highlight recent biological discoveries and emerging treatment options for this aggressive disease.
Latest:
Mucosal Melanoma: New Insights and Therapeutic Options for a Unique and Aggressive DiseaseHere, we review the features of mucosal melanoma that distinguish it from melanomas arising at other sites, and we highlight recent biological discoveries and emerging treatment options for this aggressive disease.
Latest:
Mucosal Melanoma: New Insights and Therapeutic Options for a Unique and Aggressive DiseaseHere, we review the features of mucosal melanoma that distinguish it from melanomas arising at other sites, and we highlight recent biological discoveries and emerging treatment options for this aggressive disease.
